APO Research
Talk to an analyst

APO RESEARCH · REPORT

HIV and AIDS Diagnostics

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global HIV and AIDS Diagnostics Market Analysis and Forecast 2026-2032

4 March 2026196 pages

Choose your research edition.

Industry ResearchHIV and AIDS Diagnostics Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal HIV and AIDS Diagnostics Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal HIV and AIDS Diagnostics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal HIV and AIDS Diagnostics Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal HIV and AIDS Diagnostics Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global HIV and AIDS Diagnostics market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for HIV and AIDS Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for HIV and AIDS Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for HIV and AIDS Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for HIV and AIDS Diagnostics is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of HIV and AIDS Diagnostics include Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure TechnologieS, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems and BD, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for HIV and AIDS Diagnostics, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of HIV and AIDS Diagnostics, also provides the revenue of main regions and countries. Of the upcoming market potential for HIV and AIDS Diagnostics, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the HIV and AIDS Diagnostics revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global HIV and AIDS Diagnostics market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for HIV and AIDS Diagnostics revenue, projected growth trends, production technology, application and end-user industry.

HIV and AIDS Diagnostics Segment by Company

Siemens Healthineers

Bio-Rad

Abbott Laboratories

OraSure TechnologieS

F. Hoffmann-La Roche

Hologic

Abbott

Chembio Diagnostic Systems

BD

Danaher Corporation

HIV and AIDS Diagnostics Segment by Type

Reagent Test Kit

Instrument

Others

HIV and AIDS Diagnostics Segment by Application

Hospitals

Private Diagnostic Laboratories

Academic and Research Institutes

HIV and AIDS Diagnostics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global HIV and AIDS Diagnostics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of HIV and AIDS Diagnostics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of HIV and AIDS Diagnostics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of HIV and AIDS Diagnostics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of HIV and AIDS Diagnostics company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, HIV and AIDS Diagnostics revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global HIV and AIDS Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Reagent Test Kit Major Player Table 3. Instrument Major Player Table 4. Others Major Player Table 5. Global HIV and AIDS Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospitals Major Player Table 7. Private Diagnostic Laboratories Major Player Table 8. Academic and Research Institutes Major Player Table 9. HIV and AIDS Diagnostics Industry Trends Table 10. HIV and AIDS Diagnostics Industry Drivers Table 11. HIV and AIDS Diagnostics Industry Opportunities and Challenges Table 12. HIV and AIDS Diagnostics Industry Restraints Table 13. Global HIV and AIDS Diagnostics Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global HIV and AIDS Diagnostics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global HIV and AIDS Diagnostics Market Share by Region (2021-2026) Table 16. Global HIV and AIDS Diagnostics Market Size by Region (2027-2032) & (US$ Million) Table 17. Global HIV and AIDS Diagnostics Market Share by Region (2027-2032) Table 18. Global HIV and AIDS Diagnostics Revenue by Players (US$ Million) & (2021-2026) Table 19. Global HIV and AIDS Diagnostics Revenue Market Share by Players (2021-2026) Table 20. Global HIV and AIDS Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026 Table 21. Global HIV and AIDS Diagnostics Key Players Headquarters & Area Served Table 22. Global HIV and AIDS Diagnostics Players, Product Type & Application Table 23. Global HIV and AIDS Diagnostics Players Establishment Date Table 24. Global Players Market Concentration Ratio (CR5 and HHI) Table 25. Global HIV and AIDS Diagnostics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 26. Global HIV and AIDS Diagnostics Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 28. Global HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 29. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2021-2026) Table 30. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2027-2032) Table 31. Global HIV and AIDS Diagnostics Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 32. Global HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 33. Global HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 34. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021-2026) Table 35. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2027-2032) Table 36. Siemens Healthineers Company Information Table 37. Siemens Healthineers Business Overview Table 38. Siemens Healthineers HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 39. Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio Table 40. Siemens Healthineers Recent Development Table 41. Bio-Rad Company Information Table 42. Bio-Rad Business Overview Table 43. Bio-Rad HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 44. Bio-Rad HIV and AIDS Diagnostics Product Portfolio Table 45. Bio-Rad Recent Development Table 46. Abbott Laboratories Company Information Table 47. Abbott Laboratories Business Overview Table 48. Abbott Laboratories HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 49. Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio Table 50. Abbott Laboratories Recent Development Table 51. OraSure TechnologieS Company Information Table 52. OraSure TechnologieS Business Overview Table 53. OraSure TechnologieS HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 54. OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio Table 55. OraSure TechnologieS Recent Development Table 56. F. Hoffmann-La Roche Company Information Table 57. F. Hoffmann-La Roche Business Overview Table 58. F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 59. F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio Table 60. F. Hoffmann-La Roche Recent Development Table 61. Hologic Company Information Table 62. Hologic Business Overview Table 63. Hologic HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 64. Hologic HIV and AIDS Diagnostics Product Portfolio Table 65. Hologic Recent Development Table 66. Abbott Company Information Table 67. Abbott Business Overview Table 68. Abbott HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 69. Abbott HIV and AIDS Diagnostics Product Portfolio Table 70. Abbott Recent Development Table 71. Chembio Diagnostic Systems Company Information Table 72. Chembio Diagnostic Systems Business Overview Table 73. Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 74. Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio Table 75. Chembio Diagnostic Systems Recent Development Table 76. BD Company Information Table 77. BD Business Overview Table 78. BD HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 79. BD HIV and AIDS Diagnostics Product Portfolio Table 80. BD Recent Development Table 81. Danaher Corporation Company Information Table 82. Danaher Corporation Business Overview Table 83. Danaher Corporation HIV and AIDS Diagnostics Revenue and Gross Margin (US$ Million) & (2021-2026) Table 84. Danaher Corporation HIV and AIDS Diagnostics Product Portfolio Table 85. Danaher Corporation Recent Development Table 86. North America HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 87. North America HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 88. North America HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 89. North America HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 90. North America HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 91. North America HIV and AIDS Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 92. North America HIV and AIDS Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 93. Europe HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 94. Europe HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 95. Europe HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 96. Europe HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 97. Europe HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe HIV and AIDS Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 99. Europe HIV and AIDS Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 100. China HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 101. China HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 102. China HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 103. China HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 104. Asia HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 105. Asia HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 106. Asia HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 107. Asia HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 108. Asia HIV and AIDS Diagnostics Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 109. Asia HIV and AIDS Diagnostics Revenue by Region (US$ Million) & (2021-2026) Table 110. Asia HIV and AIDS Diagnostics Revenue by Region (US$ Million) & (2027-2032) Table 111. SAMEA HIV and AIDS Diagnostics Revenue by Type (2021-2026) & (US$ Million) Table 112. SAMEA HIV and AIDS Diagnostics Revenue by Type (2027-2032) & (US$ Million) Table 113. SAMEA HIV and AIDS Diagnostics Revenue by Application (2021-2026) & (US$ Million) Table 114. SAMEA HIV and AIDS Diagnostics Revenue by Application (2027-2032) & (US$ Million) Table 115. SAMEA HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 116. SAMEA HIV and AIDS Diagnostics Revenue by Country (2021-2026) & (US$ Million) Table 117. SAMEA HIV and AIDS Diagnostics Revenue by Country (US$ Million) & (2027-2032) Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. HIV and AIDS Diagnostics Image Figure 2. Global HIV and AIDS Diagnostics Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global HIV and AIDS Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 4. Reagent Test Kit Image Figure 5. Instrument Image Figure 6. Others Image Figure 7. Global HIV and AIDS Diagnostics Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global HIV and AIDS Diagnostics Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospitals Image Figure 10. Private Diagnostic Laboratories Image Figure 11. Academic and Research Institutes Image Figure 12. Global HIV and AIDS Diagnostics Market Size (US$ Million) & (2021-2032) Figure 13. Global HIV and AIDS Diagnostics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global HIV and AIDS Diagnostics Market Share by Region: 2021 VS 2025 VS 2032 Figure 15. Global HIV and AIDS Diagnostics Players Revenue Share Top 10 and Top 5 in 2025 Figure 16. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global HIV and AIDS Diagnostics Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global HIV and AIDS Diagnostics Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global HIV and AIDS Diagnostics Revenue Market Share by Type (2021-2032) Figure 20. Global HIV and AIDS Diagnostics Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 22. Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021-2032) Figure 23. North America HIV and AIDS Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 24. North America HIV and AIDS Diagnostics Revenue Share by Type (2021-2032) Figure 25. North America HIV and AIDS Diagnostics Revenue Share by Application (2021-2032) Figure 26. North America HIV and AIDS Diagnostics Revenue Share by Country (2021-2032) Figure 27. United States HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Canada HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Mexico HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Europe HIV and AIDS Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 31. Europe HIV and AIDS Diagnostics Revenue Share by Type (2021-2032) Figure 32. Europe HIV and AIDS Diagnostics Revenue Share by Application (2021-2032) Figure 33. Europe HIV and AIDS Diagnostics Revenue Share by Country (2021-2032) Figure 34. Germany HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. France HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. U.K. HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Italy HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Spain HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Russia HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Netherlands HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Nordic Countries HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. China HIV and AIDS Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 43. China HIV and AIDS Diagnostics Revenue Share by Type (2021-2032) Figure 44. China HIV and AIDS Diagnostics Revenue Share by Application (2021-2032) Figure 45. Asia HIV and AIDS Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 46. Asia HIV and AIDS Diagnostics Revenue Share by Type (2021-2032) Figure 47. Asia HIV and AIDS Diagnostics Revenue Share by Application (2021-2032) Figure 48. Asia HIV and AIDS Diagnostics Revenue Share by Region (2021-2032) Figure 49. Japan HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. South Korea HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. India HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Australia HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Taiwan HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Southeast Asia HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. SAMEA HIV and AIDS Diagnostics Revenue YoY Growth (2021-2032) & (US$ Million) Figure 56. SAMEA HIV and AIDS Diagnostics Revenue Share by Type (2021-2032) Figure 57. SAMEA HIV and AIDS Diagnostics Revenue Share by Application (2021-2032) Figure 58. SAMEA HIV and AIDS Diagnostics Revenue Share by Country (2021-2032) Figure 59. Brazil HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Argentina HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Chile HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Colombia HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Peru HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Saudi Arabia HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Israel HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. UAE HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Turkey HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Iran HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Egypt HIV and AIDS Diagnostics Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Reagent Test Kit
  • Instrument
  • Others
Applications
  • Hospitals
  • Private Diagnostic Laboratories
  • Academic and Research Institutes
Companies covered
  • Siemens Healthineers
  • Bio-Rad
  • Abbott Laboratories
  • OraSure TechnologieS
  • F. Hoffmann-La Roche
  • Hologic
  • Abbott
  • Chembio Diagnostic Systems
  • BD
  • Danaher Corporation

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 HIV and AIDS Diagnostics Market by Type
  3. 1.2.1 Global HIV and AIDS Diagnostics Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Reagent Test Kit
  5. 1.2.3 Instrument
  6. 1.2.4 Others
  7. 1.3 HIV and AIDS Diagnostics Market by Application
  8. 1.3.1 Global HIV and AIDS Diagnostics Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospitals
  10. 1.3.3 Private Diagnostic Laboratories
  11. 1.3.4 Academic and Research Institutes
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 HIV and AIDS Diagnostics Market Dynamics
  1. 2.1 HIV and AIDS Diagnostics Industry Trends
  2. 2.2 HIV and AIDS Diagnostics Industry Drivers
  3. 2.3 HIV and AIDS Diagnostics Industry Opportunities and Challenges
  4. 2.4 HIV and AIDS Diagnostics Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global HIV and AIDS Diagnostics Market Perspective (2021-2032)
  2. 3.2 Global HIV and AIDS Diagnostics Growth Trends by Region
  3. 3.2.1 Global HIV and AIDS Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global HIV and AIDS Diagnostics Market Size by Region (2021-2026)
  5. 3.2.3 Global HIV and AIDS Diagnostics Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global HIV and AIDS Diagnostics Revenue by Players
  2. 4.1.1 Global HIV and AIDS Diagnostics Revenue by Players (2021-2026)
  3. 4.1.2 Global HIV and AIDS Diagnostics Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global HIV and AIDS Diagnostics Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global HIV and AIDS Diagnostics Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global HIV and AIDS Diagnostics Key Players Headquarters & Area Served
  7. 4.4 Global HIV and AIDS Diagnostics Players, Product Type & Application
  8. 4.5 Global HIV and AIDS Diagnostics Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global HIV and AIDS Diagnostics Market CR5 and HHI
  11. 4.6.3 2025 HIV and AIDS Diagnostics Tier 1, Tier 2, and Tier 3
5 HIV and AIDS Diagnostics Market Size by Type
  1. 5.1 Global HIV and AIDS Diagnostics Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 5.3 Global HIV and AIDS Diagnostics Revenue Market Share by Type (2021-2032)
6 HIV and AIDS Diagnostics Market Size by Application
  1. 6.1 Global HIV and AIDS Diagnostics Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  3. 6.3 Global HIV and AIDS Diagnostics Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Siemens Healthineers
  2. 7.1.1 Siemens Healthineers Company Information
  3. 7.1.2 Siemens Healthineers Business Overview
  4. 7.1.3 Siemens Healthineers HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Siemens Healthineers HIV and AIDS Diagnostics Product Portfolio
  6. 7.1.5 Siemens Healthineers Recent Developments
  7. 7.2 Bio-Rad
  8. 7.2.1 Bio-Rad Company Information
  9. 7.2.2 Bio-Rad Business Overview
  10. 7.2.3 Bio-Rad HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bio-Rad HIV and AIDS Diagnostics Product Portfolio
  12. 7.2.5 Bio-Rad Recent Developments
  13. 7.3 Abbott Laboratories
  14. 7.3.1 Abbott Laboratories Company Information
  15. 7.3.2 Abbott Laboratories Business Overview
  16. 7.3.3 Abbott Laboratories HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Abbott Laboratories HIV and AIDS Diagnostics Product Portfolio
  18. 7.3.5 Abbott Laboratories Recent Developments
  19. 7.4 OraSure TechnologieS
  20. 7.4.1 OraSure TechnologieS Company Information
  21. 7.4.2 OraSure TechnologieS Business Overview
  22. 7.4.3 OraSure TechnologieS HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  23. 7.4.4 OraSure TechnologieS HIV and AIDS Diagnostics Product Portfolio
  24. 7.4.5 OraSure TechnologieS Recent Developments
  25. 7.5 F. Hoffmann-La Roche
  26. 7.5.1 F. Hoffmann-La Roche Company Information
  27. 7.5.2 F. Hoffmann-La Roche Business Overview
  28. 7.5.3 F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  29. 7.5.4 F. Hoffmann-La Roche HIV and AIDS Diagnostics Product Portfolio
  30. 7.5.5 F. Hoffmann-La Roche Recent Developments
  31. 7.6 Hologic
  32. 7.6.1 Hologic Company Information
  33. 7.6.2 Hologic Business Overview
  34. 7.6.3 Hologic HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Hologic HIV and AIDS Diagnostics Product Portfolio
  36. 7.6.5 Hologic Recent Developments
  37. 7.7 Abbott
  38. 7.7.1 Abbott Company Information
  39. 7.7.2 Abbott Business Overview
  40. 7.7.3 Abbott HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Abbott HIV and AIDS Diagnostics Product Portfolio
  42. 7.7.5 Abbott Recent Developments
  43. 7.8 Chembio Diagnostic Systems
  44. 7.8.1 Chembio Diagnostic Systems Company Information
  45. 7.8.2 Chembio Diagnostic Systems Business Overview
  46. 7.8.3 Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Chembio Diagnostic Systems HIV and AIDS Diagnostics Product Portfolio
  48. 7.8.5 Chembio Diagnostic Systems Recent Developments
  49. 7.9 BD
  50. 7.9.1 BD Company Information
  51. 7.9.2 BD Business Overview
  52. 7.9.3 BD HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  53. 7.9.4 BD HIV and AIDS Diagnostics Product Portfolio
  54. 7.9.5 BD Recent Developments
  55. 7.10 Danaher Corporation
  56. 7.10.1 Danaher Corporation Company Information
  57. 7.10.2 Danaher Corporation Business Overview
  58. 7.10.3 Danaher Corporation HIV and AIDS Diagnostics Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Danaher Corporation HIV and AIDS Diagnostics Product Portfolio
  60. 7.10.5 Danaher Corporation Recent Developments
8 North America
  1. 8.1 North America HIV and AIDS Diagnostics Revenue (2021-2032)
  2. 8.2 North America HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 8.2.1 North America HIV and AIDS Diagnostics Revenue by Type (2021-2026)
  4. 8.2.2 North America HIV and AIDS Diagnostics Revenue by Type (2027-2032)
  5. 8.3 North America HIV and AIDS Diagnostics Revenue Share by Type (2021-2032)
  6. 8.4 North America HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  7. 8.4.1 North America HIV and AIDS Diagnostics Revenue by Application (2021-2026)
  8. 8.4.2 North America HIV and AIDS Diagnostics Revenue by Application (2027-2032)
  9. 8.5 North America HIV and AIDS Diagnostics Revenue Share by Application (2021-2032)
  10. 8.6 North America HIV and AIDS Diagnostics Revenue by Country
  11. 8.6.1 North America HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America HIV and AIDS Diagnostics Revenue by Country (2021-2026)
  13. 8.6.3 North America HIV and AIDS Diagnostics Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe HIV and AIDS Diagnostics Revenue (2021-2032)
  2. 9.2 Europe HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 9.2.1 Europe HIV and AIDS Diagnostics Revenue by Type (2021-2026)
  4. 9.2.2 Europe HIV and AIDS Diagnostics Revenue by Type (2027-2032)
  5. 9.3 Europe HIV and AIDS Diagnostics Revenue Share by Type (2021-2032)
  6. 9.4 Europe HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  7. 9.4.1 Europe HIV and AIDS Diagnostics Revenue by Application (2021-2026)
  8. 9.4.2 Europe HIV and AIDS Diagnostics Revenue by Application (2027-2032)
  9. 9.5 Europe HIV and AIDS Diagnostics Revenue Share by Application (2021-2032)
  10. 9.6 Europe HIV and AIDS Diagnostics Revenue by Country
  11. 9.6.1 Europe HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe HIV and AIDS Diagnostics Revenue by Country (2021-2026)
  13. 9.6.3 Europe HIV and AIDS Diagnostics Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China HIV and AIDS Diagnostics Revenue (2021-2032)
  2. 10.2 China HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 10.2.1 China HIV and AIDS Diagnostics Revenue by Type (2021-2026)
  4. 10.2.2 China HIV and AIDS Diagnostics Revenue by Type (2027-2032)
  5. 10.3 China HIV and AIDS Diagnostics Revenue Share by Type (2021-2032)
  6. 10.4 China HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  7. 10.4.1 China HIV and AIDS Diagnostics Revenue by Application (2021-2026)
  8. 10.4.2 China HIV and AIDS Diagnostics Revenue by Application (2027-2032)
  9. 10.5 China HIV and AIDS Diagnostics Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia HIV and AIDS Diagnostics Revenue (2021-2032)
  2. 11.2 Asia HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 11.2.1 Asia HIV and AIDS Diagnostics Revenue by Type (2021-2026)
  4. 11.2.2 Asia HIV and AIDS Diagnostics Revenue by Type (2027-2032)
  5. 11.3 Asia HIV and AIDS Diagnostics Revenue Share by Type (2021-2032)
  6. 11.4 Asia HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  7. 11.4.1 Asia HIV and AIDS Diagnostics Revenue by Application (2021-2026)
  8. 11.4.2 Asia HIV and AIDS Diagnostics Revenue by Application (2027-2032)
  9. 11.5 Asia HIV and AIDS Diagnostics Revenue Share by Application (2021-2032)
  10. 11.6 Asia HIV and AIDS Diagnostics Revenue by Country
  11. 11.6.1 Asia HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia HIV and AIDS Diagnostics Revenue by Country (2021-2026)
  13. 11.6.3 Asia HIV and AIDS Diagnostics Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA HIV and AIDS Diagnostics Revenue (2021-2032)
  2. 12.2 SAMEA HIV and AIDS Diagnostics Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA HIV and AIDS Diagnostics Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA HIV and AIDS Diagnostics Revenue by Type (2027-2032)
  5. 12.3 SAMEA HIV and AIDS Diagnostics Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA HIV and AIDS Diagnostics Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA HIV and AIDS Diagnostics Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA HIV and AIDS Diagnostics Revenue by Application (2027-2032)
  9. 12.5 SAMEA HIV and AIDS Diagnostics Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA HIV and AIDS Diagnostics Revenue by Country
  11. 12.6.1 SAMEA HIV and AIDS Diagnostics Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA HIV and AIDS Diagnostics Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA HIV and AIDS Diagnostics Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst